Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Artivion
Company

Artivion

Tracked across 2 events · 12 articles · First seen May 18, 2026 · Last active Jun 29, 2026

Sentiment
62
Attention
6
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
4 50
Business
Artivion acquires Endospan after FDA approval
Impact: Artivion>>> acquired Endospan>>> for $135 million upfront, strengthening its position in the aortic device market and completing its aortic arch portfolio. This acquisition is expected to expand Artivion>>>'s leadership in the aortic arch market.
May 18, 2026 · 6 articles
6 75
Tech
Artivion AMDS Prosthesis FDA Approval
Impact: Artivion received PMA approval for its AMDS Hybrid Prosthesis, which is expected to accelerate adoption and allow the company to fully penetrate the estimated $150 million annual U.S. market opportunity. This approval strengthens Artivion's position in aortic arch solutions.
Jun 29, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Artivion live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.